• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

癌症免疫疗法洞察：近期突破、机遇与挑战

Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.

作者信息

Pappas Evan G, Kershaw Michael H, Slaney Clare Y

机构信息

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3010, Australia.

出版信息

Cancers (Basel). 2023 Feb 19;15(4):1322. doi: 10.3390/cancers15041322.

DOI:10.3390/cancers15041322
PMID:36831663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9954646/
Abstract

This Special Issue reminds us that, although incredible developments have occurred in the field of cancer immunotherapy, there is still plenty of room for improvement [...].

摘要

本期特刊提醒我们，尽管癌症免疫治疗领域已经取得了令人难以置信的进展，但仍有很大的改进空间[...]。

相似文献

1
Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges.癌症免疫疗法洞察：近期突破、机遇与挑战
Cancers (Basel). 2023 Feb 19;15(4):1322. doi: 10.3390/cancers15041322.
2
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma.弥漫性脑桥内在型胶质瘤的免疫微环境与免疫疗法
Cancers (Basel). 2023 Jan 18;15(3):602. doi: 10.3390/cancers15030602.
3
Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer.胰腺癌靶向治疗和免疫治疗中的机遇与挑战。
Expert Rev Mol Med. 2021 Dec 15;23:e21. doi: 10.1017/erm.2021.26.
4
Cancer Immunotherapy, Part 3: Challenges and Future Trends.癌症免疫疗法，第3部分：挑战与未来趋势。
P T. 2017 Aug;42(8):514-521.
5
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs.骨肉瘤的免疫治疗：基础机制、原理和最新突破。
Cancer Lett. 2021 Mar 1;500:1-10. doi: 10.1016/j.canlet.2020.12.024. Epub 2020 Dec 23.
6
Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data.多重免疫荧光数据统计分析中的挑战与机遇
Cancers (Basel). 2021 Jun 17;13(12):3031. doi: 10.3390/cancers13123031.
7
Immunoengineering with biomaterials for enhanced cancer immunotherapy.生物材料在增强癌症免疫治疗中的免疫工程学应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jul;10(4):e1506. doi: 10.1002/wnan.1506. Epub 2018 Jan 14.
8
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape.癌症免疫疗法：快速发展的临床领域中的机遇与挑战。
Eur J Cancer. 2017 Aug;81:116-129. doi: 10.1016/j.ejca.2017.01.035. Epub 2017 Jun 15.
9
Improving safety of cancer immunotherapy via delivery technology.通过递送技术提高癌症免疫疗法的安全性。
Biomaterials. 2021 Jan;265:120407. doi: 10.1016/j.biomaterials.2020.120407. Epub 2020 Sep 20.
10
A brand new era of cancer immunotherapy: breakthroughs and challenges.癌症免疫治疗的新纪元：突破与挑战。
Chin Med J (Engl). 2021 May 19;134(11):1267-1275. doi: 10.1097/CM9.0000000000001490.

本文引用的文献

1
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma.联合BRAF-MEK和CDK4/6抑制剂增强黑色素瘤的过继性细胞转移
Cancers (Basel). 2021 Dec 17;13(24):6342. doi: 10.3390/cancers13246342.
2
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy.非复制型腺病毒载体：改善癌症基因治疗的靶向性与递送
Cancers (Basel). 2021 Apr 14;13(8):1863. doi: 10.3390/cancers13081863.
3
Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.Ropporin-1和1B在人类黑色素瘤中广泛表达并引发强烈的体液免疫反应。
Cancers (Basel). 2021 Apr 9;13(8):1805. doi: 10.3390/cancers13081805.
4
Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?人表皮生长因子受体2阳性乳腺癌中的免疫检查点阻断：在早期疾病中的作用是什么？
Cancers (Basel). 2021 Apr 1;13(7):1655. doi: 10.3390/cancers13071655.
5
Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma.预先加载到脂肪来源间充质干细胞中的表达LIGHT（肿瘤坏死因子配体超家族成员14）的黏液瘤病毒是治疗小鼠胰腺腺癌的有效方法。
Cancers (Basel). 2021 Mar 19;13(6):1394. doi: 10.3390/cancers13061394.
6
TAM Receptor Inhibition-Implications for Cancer and the Immune System.TAM 受体抑制作用——对癌症和免疫系统的影响
Cancers (Basel). 2021 Mar 10;13(6):1195. doi: 10.3390/cancers13061195.
7
Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)-T Cells.嵌合抗原受体（CAR）-T细胞中的代谢与线粒体功能
Cancers (Basel). 2021 Mar 11;13(6):1229. doi: 10.3390/cancers13061229.
8
Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model.在Jurkat T细胞模型中，将嵌合抗原受体（CAR）靶向至肽-主要组织相容性复合体（peptide-MHC complex）所揭示的信号传导与T细胞受体（TCR）不同。
Cancers (Basel). 2021 Feb 18;13(4):867. doi: 10.3390/cancers13040867.
9
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.自然杀伤细胞与抗癌疗法：对免疫功能和治疗反应的相互影响
Cancers (Basel). 2021 Feb 9;13(4):711. doi: 10.3390/cancers13040711.
10
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.利用肿瘤坏死因子α实现有效的癌症免疫治疗。
Cancers (Basel). 2021 Feb 2;13(3):564. doi: 10.3390/cancers13030564.